RUA Life Sciences PLC (LSE:RUA) Share Price

Company Profile

Business description
RUA Life Sciences PLC is engaged in contract design and manufacture of medical devices and exploiting the value of its IP and know-how, and developing of cardiovascular devices. Its segments include Biomaterials includes Licensor of Elast-Eon polymers to the medical device industry; Medical Devices and Components engages End-to-end contract developer, manufacturer, and seller of medical devices and implantable fabric specialist; Vascular engages in the development and commercialization of the group’s Elast-Eon sealed Vascular Graft products; and Structural Heart engages in the development of the group’s Elast-Eon composite heart valve material AurTex. Geographically it operates in Europe, North America, Middle East , Asia Pacific, and Africa.
Contact
2 Drummond Crescent
Ayrshire
Scotland
IrvineKA11 5AN
GBR
T: +44 1294317073
E: [email protected]
https://www.rualifesciences.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2026
Employees
40

Recommended

We think Microsoft stock is moderately undervalued.

Dan Romanoff, CPA | 30 October 2025

Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.

Seth Goldstein, CFA | 30 October 2025

Well priced Aussie shares that offer a tax rebate.

Shani Jayamanne | 29 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,178.00	28.70	-0.31%
CAC 40	8,121.07	36.22	-0.44%
DAX 40	23,958.30	160.59	-0.67%
Dow JONES (US)	47,562.87	40.75	0.09%
FTSE 100	9,717.25	42.81	-0.44%
HKSE	25,906.65	376.04	-1.43%
NASDAQ	23,724.96	143.81	0.61%
Nikkei 225	52,411.34	1,085.73	2.12%
NZX 50 Index	13,548.32	89.03	0.66%
S&P 500	6,840.20	17.86	0.26%
S&P/ASX 200	8,881.90	31.30	-0.35%
SSE Composite Index	3,954.79	32.11	-0.81%